deal
Resonance Health agrees to acquire TrialsWest
Subject to meeting specific conditions, the deal is anticipated to conclude in the last quarter of FY 2024.
Subject to meeting specific conditions, the deal is anticipated to conclude in the last quarter of FY 2024.